This is provisional, machine-derived output — not a graded claim, not a recommendation, and not a safety assessment. Human review of the underlying source is not yet complete.
Source kind
pubmed_abstract
Correction status
current
Review status
Assigned — pending review — Source registered and assignment complete. Dual human review, adjudication (if disagreement is found), and final lock are pending.
Ascophyllan Supplementation Is Safe and Associated with Exploratory Modulation of Innate Immune Phenotypes, Biochemical Parameters, and the Gut Microbiome in a Randomized Pilot Trial.